Proinflammatory cytokine production pathways in human dermal microvessel endothelial cells

Proinflammatory cytokine production pathways in human dermal microvessel endothelial cells (HDMECs) represent the coordinated molecular events that drive cutaneous inflammation (Source: PubMed). These pathways are typically initiated by exogenous or endogenous stressors, such as TNF-alpha or IL-1 beta, which bind to their respective receptors on the HDMEC surface (Source: Journal of Investigative Dermatology). This binding triggers intracellular signaling through the NF-kappaB, MAPK, and JAK/STAT pathways, leading to the transcriptional upregulation of various inflammatory mediators (Source: NIH). Key products include chemokines like IL-8 and adhesion molecules like ICAM-1, which are essential for the recruitment and extravasation of leukocytes into the skin (Source: StatPearls). While these pathways are vital for normal host defense and wound healing, their chronic activation is a primary driver of inflammatory skin diseases such as psoriasis and dermatitis (Source: PubMed). Pharmacological intervention often targets specific components of these pathways, such as cytokine neutralization or kinase inhibition, to alleviate symptoms and reduce tissue damage (Source: PubChem). Understanding the specific dynamics of these pathways in HDMECs is crucial for developing targeted therapies that minimize systemic side effects while treating localized skin inflammation (Source: PubMed).

Other names

HDMEC inflammatory signalingDermal endothelial cytokine pathwaysCytokine production in dermal microvascular endothelial cells

Modulation of cytokine signaling through inhibition of ligands, receptors, or downstream intracellular signaling molecules such as kinases and transcription factors (Source: PubMed).